Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 107 (1) , 40-51
- https://doi.org/10.1016/0008-8749(87)90264-4
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Clinical Evaluation of the Immunoadjuvant Murabutide, a Derivative of MDP, Administered with a Tetanus Toxoid VaccineThe Journal of Infectious Diseases, 1986
- Epitope specific immunity elicited by a synthetic streptococcal antigen without carrier or adjuvantBiochemical and Biophysical Research Communications, 1983
- Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memoryThe Journal of Experimental Medicine, 1982
- Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responsesThe Journal of Experimental Medicine, 1982
- Epitope‐specific regulation. III. Induction of allotype‐restricted suppression for IgG antibody responses to individual epitopes on complex antigensEuropean Journal of Immunology, 1982
- Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptidesJournal of Medicinal Chemistry, 1982
- Carrier-priming leads to hapten-specific suppressionNature, 1980
- The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes. I. Proliferative response.The Journal of Experimental Medicine, 1977
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974
- Effect of Carrier Preimmunization on the Anti-Hapten Response in the ChickenScandinavian Journal of Immunology, 1974